日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Statins markedly potentiate aminopeptidase inhibitor activity against (drug-resistant) human acute myeloid leukemia cells

他汀类药物显著增强氨基肽酶抑制剂对(耐药性)人类急性髓系白血病细胞的活性

Gerrit Jansen, Marjon Al, Yehuda G Assaraf, Sarah Kammerer, Johan van Meerloo, Gert J Ossenkoppele, Jacqueline Cloos, Godefridus J Peters

Pre-Clinical Evaluation of the Proteasome Inhibitor Ixazomib against Bortezomib-Resistant Leukemia Cells and Primary Acute Leukemia Cells

蛋白酶体抑制剂伊沙佐米对硼替佐米耐药白血病细胞和原发性急性白血病细胞的临床前评估

Margot S F Roeten, Johan van Meerloo, Zinia J Kwidama, Giovanna Ter Huizen, Wouter H Segerink, Sonja Zweegman, Gertjan J L Kaspers, Gerrit Jansen, Jacqueline Cloos

Phosphotyrosine-based Phosphoproteomics for Target Identification and Drug Response Prediction in AML Cell Lines

基于磷酸酪氨酸的磷酸蛋白质组学用于 AML 细胞系中的靶标识别和药物反应预测

Carolien van Alphen, Jacqueline Cloos, Robin Beekhof, David G J Cucchi, Sander R Piersma, Jaco C Knol, Alex A Henneman, Thang V Pham, Johan van Meerloo, Gert J Ossenkoppele, Henk M W Verheul, Jeroen J W M Janssen, Connie R Jimenez

Exosomes Secreted by Apoptosis-Resistant Acute Myeloid Leukemia (AML) Blasts Harbor Regulatory Network Proteins Potentially Involved in Antagonism of Apoptosis

抗凋亡急性髓系白血病 (AML) 母细胞分泌的外泌体含有可能参与拮抗凋亡的调控网络蛋白

Anna Wojtuszkiewicz, Gerrit J Schuurhuis, Floortje L Kessler, Sander R Piersma, Jaco C Knol, Thang V Pham, Gerrit Jansen, René J P Musters, Johan van Meerloo, Yehuda G Assaraf, Gertjan J L Kaspers, Sonja Zweegman, Jacqueline Cloos, Connie R Jimenez

Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitors

硼替佐米耐药白血病细胞中多泛素化蛋白质的胞吐:MARCKS 在获得性蛋白酶体抑制剂耐药中的作用

Niels E Franke, Gertjan L Kaspers, Yehuda G Assaraf, Johan van Meerloo, Denise Niewerth, Floortje L Kessler, Pino J Poddighe, Jeroen Kole, Serge J Smeets, Bauke Ylstra, Chonglei Bi, Wee Joo Chng, Terzah M Horton, Rene X Menezes, Renée J P Musters, Sonja Zweegman, Gerrit Jansen, Jacqueline Cloos

Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors

通过抗 CD20/利妥昔单抗介导的补体依赖性细胞毒性和基于环氧酮的不可逆蛋白酶体抑制剂克服人类 B 细胞对硼替佐米的耐药性

Sue Ellen Verbrugge, Marjon Al, Yehuda G Assaraf, Denise Niewerth, Johan van Meerloo, Jacqueline Cloos, Michael van der Veer, George L Scheffer, Godefridus J Peters, Elena T Chan, Janet L Anderl, Christopher J Kirk, Sonja Zweegman, Ben Ac Dijkmans, Willem F Lems, Rik J Scheper, Tanja D de Gruijl, Ge